ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #4,059Gold OA

Pharmaceutical Biology

Acronym:nphb
•
Abbreviation (ISO):PHARM. BIOL
•
Identifier (ISSN):1388-0209(Print)/1744-5116(Online)
•
Publisher:Taylor and Francis Ltd.
Clarivate IF (2026)
6↑ +1.2
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Pharmaceutical Biology

WoS Q1
13681.9220182.4920192.9720203.520213.8920223.820233.920244.8202562026
Annual Impact Factor Metric
Current (2026):6
Scopus SJR & RankScopus Q1
1.121
#4,059

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
103

103 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate2.6%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessGold OA
165articles/year
100% Gold OA•93.95% Original Research

Aims & Scope

Pharmaceutical Biology will publish manuscripts describing the discovery, methods for discovery, description, analysis characterization, and production/isolation (including sources and surveys) of biologically-active chemicals or other substances, drugs, pharmaceutical products, or preparations utilized in systems of traditional medicine. Topics may generally encompass any facet of natural product research related to pharmaceutical biology. Papers dealing with agents or topics related to natural product drugs are also appropriate (e.g., semi-synthetic derivatives). Manuscripts will be published as reviews, perspectives, regular research articles, and short communications. The primary criteria for acceptance and publication are scientific rigor and potential to advance the field.

Topics Covered (Recognized by AI)
BiologyMedicineChemistryBiochemistryGeneticsOrganic ChemistryInternal MedicinePharmacologyPlant SciencesEndocrinologyGeologyPaleontologyEcologyPhysicsPathologyGeographyNuclear Magnetic ResonanceEnzymologyHistoryArchaeologyImmunologyChromatography
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

MEDICAL LABORATORY TECHNOLOGY

Q1
Rank5/33
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank46/356
IndexSCIE
JCRSCIE2026

PLANT SCIENCES

Q1
Rank32/285
IndexSCIE
JCISCIE2026

MEDICAL LABORATORY TECHNOLOGY

Q1
Rank4/33
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank17/356
IndexSCIE
JCISCIE2026

PLANT SCIENCES

Q1
Rank16/285
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF6
Articles / Year43
Total Citations33
2025
IF4.8
Articles / Year63
Total Citations313
2024
IF3.9
Articles / Year60
Total Citations725
2023
IF3.8
Articles / Year131
Total Citations2,152
2022
IF3.889
Articles / Year218
Total Citations4,140

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #4,059Scopus Q1SCImago Profile
Scopus Coverage:1961-1972, 1975-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyMedicinePharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.121

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
6.46

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,216 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations2,535
3-Year Documents410
Citable Documents409

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate47.5%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Complementary and Alternative MedicineQ1
Drug DiscoveryQ1
Medicine (miscellaneous)Q1
Pharmaceutical ScienceQ1
PharmacologyQ1
Molecular MedicineQ2
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.6%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区PLANT SCIENCES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Pharmaceutical Biology (acronym: nphb, abbr: PHARM. BIOL, ISSN: 1388-0209) is a peer-reviewed international scholarly journal in the field of Medicine, published by Taylor and Francis Ltd. in Netherlands since 1998. The periodical holds a Journal Impact Factor (JIF) of 6.00, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.121 (Q1), an H-index of 103.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 165 scientific articles. In terms of accessibility and author fees, it operates under the Gold OA model with an estimated APC of $3,216 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Gold OA
Publisher
Taylor and Francis Ltd.
Publication Language
English
Frequency
Bimonthly
Founding Year
1998
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
TAYLOR & FRANCIS INC, 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, USA, PA, 19106

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 447ff751-c85d-4ddc-8854-cbcc2f875f40
Database Updated: 2026-09-28